Marantz Jing L. 4
4 · Scholar Rock Holding Corp · Filed Oct 7, 2024
Insider Transaction Report
Form 4
Marantz Jing L.
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-10-07$26.22/sh−2,552$66,923→ 112,230 total - Sale
Common Stock
2024-10-07$25.59/sh−67,448$1,725,893→ 114,782 total - Sale
Common Stock
2024-10-07$30.06/sh−39,375$1,183,652→ 72,855 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-10-07−109,375→ 140,625 totalExercise: $8.59Exp: 2032-11-14→ Common Stock (109,375 underlying) - Exercise/Conversion
Common Stock
2024-10-07$8.59/sh+109,375$939,531→ 182,230 total
Footnotes (5)
- [F1]These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.15 to $26.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.20 to $26.335, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.44, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F5]Options vest over four years with 25% vesting on November 9, 2023 and the remainder vesting in 12 quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer as of the applicable vesting date.